 |
Aimmune Therapeutics
Last updated: May 06, 2024
Founder Bryan Walser
Country: USA | Funding: $540M (+)
Website: http://www.aimmune.com/
Aimmune Therapeutics is a clinical-stage biopharmaceutical company developing a therapeutic approach, including the development of product candidates, for the treatment of peanut and other food allergies.
Website: http://www.aimmune.com/
Aimmune Therapeutics is a clinical-stage biopharmaceutical company developing a therapeutic approach, including the development of product candidates, for the treatment of peanut and other food allergies.
